SCHEMBL8226199

SCHEMBL8226199

CN1CCC(CNC(=O)c2n[nH]cc2NC(=O)c2c(F)cccc2F)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNA2 P20248 2/20 0.53
▸ CDK2 P24941 2/20 0.53
▸ CDK1 P06493 1/20 0.48
▸ CCNB1 P14635 1/20 0.48
▸ GSK3B P49841 8/20 0.47
▸ DYRK1A Q13627 2/20 0.45
▸ LYN P07948 1/20 0.45
▸ GRK2 P25098 1/20 0.45
▸ CLK1 P49759 1/20 0.45
▸ GSK3A P49840 1/20 0.45
▸ KCNH2 Q12809 1/20 0.45
▸ MAPK7 Q13164 1/20 0.45
▸ DYRK2 Q92630 1/20 0.45
▸ NAMPT P43490 1/20 0.41
▸ BCL3 P20749 1/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ PIM3 Q86V86 1/20 0.41
▸ PIM2 Q9P1W9 1/20 0.41
▸ CHRM5 P08912 1/20 0.41
▸ DRD5 P21918 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8219161 0.91 CCNA2 (0.63) CCNA2CDK2CDK1CCNB1GSK3B
SCHEMBL13543788 0.90 CCNA2 (0.48) CCNA2CDK2CDK1CCNB1GSK3B
SCHEMBL8261337 0.88 CCNA2 (0.57) CCNA2CDK2CDK1CCNB1GSK3B
SCHEMBL8219257 0.87 CDK2 (0.56) CCNA2CDK2CDK1CCNB1PIM1
SCHEMBL8228035 0.86 CCNA2 (0.55) CCNA2CDK2GSK3BKCNH2BCL3
SCHEMBL953496 0.85 DYRK1A (0.51) CCNA2CDK2CDK1CCNB1DYRK1A
SCHEMBL8228006 0.83 CDK2 (0.49) CCNA2CDK2CDK1CCNB1GSK3B
SCHEMBL8219744 0.82 CDK2 (0.50) CCNA2CDK2CDK1CCNB1ADORA2A
SCHEMBL8262274 0.82 CDK2 (0.50) CCNA2CDK2CDK1CCNB1ADORA2A
SCHEMBL1286718 0.82 CDK2 (0.50) CCNA2CDK2CDK1CCNB1GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1651612-B9 3,4-DISUBSTITUTED 1H-PYRAZOLE COMPOUNDS AND THEIR USE AS CYCLIN DEPENDENT KINASES (CDK) AND GLYCOGEN SYNTHASE KINASE-3 (GSK-3) MODULATORS ASTEX THERAPEUTICS LTD (GB) 2012-09-05 — — EP disclosed
WO-2008007113-A2 PHARMACEUTICAL COMBINATIONS ASTEX THERAPEUTICS LIMITED (GB) 2008-01-17 — — WO disclosed
Send feedback